Comparative Effectiveness and Safety of Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin Receptor Blockers (ARBs) in Older Adults with Type 2 DiabetesFirst published 04/01/2022 Last updated 02/07/2024 EU PAS number: EUPAS44899StudyFinalised
University of North Carolina at Chapel Hill First published: 01/02/2024Last updated 01/02/2024 Institution